PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmccancBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Cancer
 
BMC Cancer. 2012; 12: 504.
Published online Oct 31, 2012. doi:  10.1186/1471-2407-12-504
PMCID: PMC3495015
Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial
Sonja Krause,corresponding author1 Florian Sterzing,1 Dirk Neuhof,1 Lutz Edler,2 Juergen Debus,1 and Klaus Herfarth2
1Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany
2Department of Biostatistics, German Cancer Research Center, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany
corresponding authorCorresponding author.
Sonja Krause: sonja.krause/at/med.uni-heidelberg.de; Florian Sterzing: florian.sterzing/at/med.uni-heidelberg.de; Dirk Neuhof: dirk.neuhof/at/med.uni-heidelberg.de; Lutz Edler: edler/at/dkfz-heidelberg.de; Juergen Debus: juergen.debus/at/med.uni-heidelberg.de; Klaus Herfarth: klaus.herfarth/at/med.uni-heidelberg.de
Received June 5, 2012; Accepted October 19, 2012.
Abstract
Background
While evidence on safety and efficacy of primary hypofractionated radiotherapy in prostate cancer is accumulating, data on postoperative hypofractionated treatment of the prostate bed and of the pelvic lymph nodes is still scarce. This phase II trial was initiated to investigate safety and feasibility of hypofractionated treatment of the prostate bed alone or with the pelvic lymph nodes.
Methods/design
A total of 80 prostate cancer patients with the indication for adjuvant radiotherapy will be enrolled, where 40 patients with a low risk of lymph node involvement (arm 1) and another 40 patients with a high risk of lymph node involvement (arm 2) will each receive 54 Gy in 18 fractions to the prostate bed. Arm 2 will be given 45 Gy to the pelvic lymph nodes additionally. Helical Tomotherapy and daily image guidance will be used.
Discussion
This trial was initiated to substantiate data on hypofractionated treatment of the prostate bed and generate first data on adjuvant hypofractionated radiotherapy of the pelvic lymph nodes.
Trial registration
ClinicalTrials.gov; NCT01620710
Keywords: Prostate cancer, Radiotherapy, Hypofractionation, Helical tomotherapy, Prostate bed, Pelvic lymph nodes
Articles from BMC Cancer are provided here courtesy of
BioMed Central